Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1056)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,504
Price
$519.51
Total Value
$781.34K
Shares Held After
331,463
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
976
Price
$518.45
Total Value
$506.01K
Shares Held After
332,967
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
120
Price
$527.21
Total Value
$63.27K
Shares Held After
45,172
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
400
Price
$526.38
Total Value
$210.55K
Shares Held After
45,292
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
940
Price
$525.25
Total Value
$493.74K
Shares Held After
45,692
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
192
Price
$523.69
Total Value
$100.55K
Shares Held After
46,632
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
850
Price
$522.78
Total Value
$444.37K
Shares Held After
46,824
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
787
Price
$522.00
Total Value
$410.82K
Shares Held After
47,674
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,819
Price
$521.04
Total Value
$947.77K
Shares Held After
48,461
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
502
Price
$520.03
Total Value
$261.06K
Shares Held After
50,280
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,690
Price
$524.15
Total Value
$1.41M
Shares Held After
50,782
% of Holdings
5.0%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
114,700
Price
$4.54
Total Value
$520.74K
Shares Held After
2,465,298
% of Holdings
4.4%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
3,056
Price
$44.16
Total Value
$134.95K
Shares Held After
219,301
% of Holdings
1.4%
Liquidia Corp (LQDA)
Rielly-Gauvin Katherine — Director
Shares
18,393
Price
$72.23
Total Value
$1.33M
Shares Held After
44,637
% of Holdings
29.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$8.79
Total Value
$439.43K
Shares Held After
800,000
% of Holdings
6.2%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
16,634
Price
$0.59
Total Value
$9.81K
Shares Held After
53,533
% of Holdings
31.1%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
7,342
Price
$62.12
Total Value
$456.09K
Shares Held After
961,194
% of Holdings
0.8%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
36,373
Price
$61.11
Total Value
$2.22M
Shares Held After
968,536
% of Holdings
3.6%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
47,307
Price
$60.17
Total Value
$2.85M
Shares Held After
1,004,909
% of Holdings
4.5%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
6,495
Price
$0.32
Total Value
$2.08K
Shares Held After
7,850,155
% of Holdings
0.1%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
46
Price
$0.32
Total Value
$14.72
Shares Held After
55,208
% of Holdings
0.1%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
1,159
Price
$0.32
Total Value
$370.88
Shares Held After
1,400,560
% of Holdings
0.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
6,495
Price
$0.32
Total Value
$2.08K
Shares Held After
7,850,155
% of Holdings
0.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
46
Price
$0.32
Total Value
$14.72
Shares Held After
55,208
% of Holdings
0.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,159
Price
$0.32
Total Value
$370.88
Shares Held After
1,400,560
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
172,899
Price
$37.17
Total Value
$6.43M
Shares Held After
18,630,739
% of Holdings
0.9%
Nuvation Bio Inc. (NUVB)
Hattersley Gary — CHIEF SCIENTIFIC OFFICER
Shares
100,000
Price
$7.09
Total Value
$709.24K
Shares Held After
0
% of Holdings
100.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
7,165
Price
$73.67
Total Value
$527.85K
Shares Held After
1,374,094
% of Holdings
0.5%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
5,335
Price
$72.86
Total Value
$388.71K
Shares Held After
1,381,259
% of Holdings
0.4%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
45,147
Price
$4.76
Total Value
$214.90K
Shares Held After
2,579,998
% of Holdings
1.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
1,697
Price
$27.00
Total Value
$45.82K
Shares Held After
117,592
% of Holdings
1.4%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
25,927
Price
$16.42
Total Value
$425.65K
Shares Held After
825,819
% of Holdings
3.0%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
43,149
Price
$15.36
Total Value
$662.62K
Shares Held After
851,746
% of Holdings
4.8%
ACHIEVE LIFE SCIENCES, INC. (ACHV)
Stewart Richard Alistair — Director
Shares
20,626
Price
$8.49
Total Value
$175.18K
Shares Held After
208,249
% of Holdings
9.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
4,884
Price
$14.00
Total Value
$68.38K
Shares Held After
141,053
% of Holdings
3.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
23,584
Price
$14.00
Total Value
$330.18K
Shares Held After
681,197
% of Holdings
3.3%
Liquidia Corp (LQDA)
Rielly-Gauvin Katherine — Director
Shares
36,789
Price
$74.99
Total Value
$2.76M
Shares Held After
44,637
% of Holdings
45.2%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
260
Price
$27.00
Total Value
$7.02K
Shares Held After
35,635
% of Holdings
0.7%
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
31,487
Price
$12.63
Total Value
$397.68K
Shares Held After
195,444
% of Holdings
13.9%
Viridian Therapeutics, Inc.\DE (VRDN)
Tousignant Jennifer — Chief Legal Officer
Shares
10,000
Price
$24.50
Total Value
$245.00K
Shares Held After
0
% of Holdings
100.0%
Viridian Therapeutics, Inc.\DE (VRDN)
Tousignant Jennifer — Chief Legal Officer
Shares
4,212
Price
$24.50
Total Value
$103.19K
Shares Held After
0
% of Holdings
100.0%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
8,978
Price
$62.65
Total Value
$562.47K
Shares Held After
1,052,216
% of Holdings
0.8%
MACROGENICS INC (MGNX)
Peters Jeffrey Stuart — Senior VP, GC, and Secretary
Shares
31,105
Price
$4.15
Total Value
$129.09K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
57,476
Price
$0.35
Total Value
$20.12K
Shares Held After
7,856,650
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
409
Price
$0.35
Total Value
$143.15
Shares Held After
55,254
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
10,255
Price
$0.35
Total Value
$3.59K
Shares Held After
1,401,719
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
57,476
Price
$0.35
Total Value
$20.12K
Shares Held After
7,856,650
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
409
Price
$0.35
Total Value
$143.15
Shares Held After
55,254
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
10,255
Price
$0.35
Total Value
$3.59K
Shares Held After
1,401,719
% of Holdings
0.7%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
10,801
Price
$125.56
Total Value
$1.36M
Shares Held After
183,200
% of Holdings
5.6%
1056 transactions